NetworkNewsBreaks – Endonovo Therapeutics Inc. (
Post# of 416
Endonovo Therapeutics (OTCQB: ENDV), a commercial-stage developer of noninvasive Electroceutical(R) therapeutic devices, today announced that the company has determined to effect a 1-for-1,000 reverse stock split of its issued common shares. According to the update, the reverse stock split will take effect, and the company’s common stock will begin trading on a split-adjusted basis on the OTCQB under the ticker symbol “ENDVD” upon completion of FINRA review. Upon effective date of the reverse stock split, every 1,000 shares of the company’s issued and outstanding common stock will be automatically combined into one issued and outstanding share of common stock without any change in the par value per share or the total number of authorized shares.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer